Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises BICO in connection with a directed issue of new shares for SEK 2 billion
Mandate

Vinge advises BICO in connection with a directed issue of new shares for SEK 2 billion

October 08, 2021 Capital Markets and Public M&A

Vinge has advised BICO Group AB in connection with a directed issue of new shares for approximately SEK 2 billion.

The subscription price of SEK 480 was set pursuant to an accelerated bookbuilding procedure arranged by Carnegie, J.P. Morgan, ABG and Bryan Garnier. BICO intends to use the issue proceeds to finance the acquisition of QInstruments as well as to further promote the Company’s acquisition agenda and create financial preparedness regarding new possibilities.

Vinge’s team consisted of Anders Strid, Edin Agic and Adrian Filipovic.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026